Neonc Technologies Hldgs (NTHI) closed at $3.07 on November 3, 2026, unchanged from the previous close, on volume of 48,913 shares (30-day average 143,466).
Data as of November 3, 2026.
NeOnc Presents NEO100 and NEO212 Data at SNO Meeting
TipRanks (Tue, 3-Nov 6:13 PM ET)
Four Elevated Short Interest Stocks as Oil Retreats and Midterm Elections Approach
Globe Newswire (Tue, 3-Nov 10:13 AM ET)
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
Globe Newswire (Mon, 2-Nov 11:00 AM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
NeOnc's Ambitious Brain Cancer Plans are Setting the Stage
Globe Newswire (Fri, 30-Oct 9:10 AM ET)
2027 Could Finally Be the Year Cancer Is on the Ropes!
Globe Newswire (Thu, 29-Oct 9:10 PM ET)
Defining Moments in the Race for Biotech Breakthroughs
Globe Newswire (Mon, 26-Oct 10:44 AM ET)
Globe Newswire (Mon, 26-Oct 9:19 AM ET)
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue
Globe Newswire (Fri, 23-Oct 1:01 PM ET)
Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly's Next Growth Chapter
Globe Newswire (Thu, 22-Oct 2:27 PM ET)
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Neonc Technologies Hldgs trades on the NASDAQ stock market under the symbol NTHI.
As of November 3, 2026, NTHI stock price was flat at $3.07 with 48,913 million shares trading.
NTHI has a beta of 2.78, meaning it tends to be more sensitive to market movements. NTHI has a correlation of 0.09 to the broad based SPY ETF.
NTHI has a market cap of $88.43 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that NTHI belongs to (by Net Assets): VTI, VXF, IWC, BUSM.
NTHI has underperformed the market in the last year with a return of -68.7%, while the SPY ETF gained +11.7%. In the last 3 month period, NTHI fell short of the market, returning -12.0%, while SPY returned +1.2%. However, in the most recent 2 weeks NTHI has outperformed the stock market by returning +12.9%, while SPY returned -1.6%.
NTHI support price is $2.86 and resistance is $3.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NTHI shares will trade within this expected range on the day.
